Prime Medicine, Inc.PRMENASDAQ
Loading
EPS Growth Under PressureDecelerating
Percentile Rank81
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

Latest
18.75%
↑ 114% vs avg
Percentile
P81
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
-137.19%
Historical baseline
PeriodValue
Q4 202518.75%
Q3 202521.40%
Q2 2025-2.67%
Q1 2025-11.22%
Q4 202418.70%
Q3 20245.54%
Q2 2024-5.98%
Q1 202435.02%
Q4 2023-22.10%
Q3 2023-17.84%
Q2 2023-5.92%
Q1 2023-5.91%
Q4 2022-13.66%
Q3 20221.32%
Q2 2022-18.57%
Q1 202256.61%
Q4 2021-204.16%
Q3 2021-440.68%
Q2 202195.21%
Q1 2021-2522.00%
Q4 20200.00%
Q4 20190.00%